#Germany #Digital Transformation #Berlin #ISPE Pharma 4.0 #Biopharma Conference

Unveiling the 2026 ISPE Pharma 4.0™ and Biopharma Conference

The International Society for Pharmaceutical Engineering (ISPE) is gearing up for an exciting event—the 2026 ISPE Pharma 4.0™ and Biopharma Conference. This event is set to take place on December 10-11, 2026, in Berlin, Germany, as well as virtually, allowing broad accessibility for industry professionals worldwide.

This year's conference is distinct as it is the first international gathering to marry the principles of Pharma 4.0™ with biopharmaceutical topics into a single, integrated program. Attendees can look forward to engaging discussions across three technical tracks that cover:

• - Digital enablement
• - Compliant operations
• - Practical transformation of biopharma manufacturing through Pharma 4.0™

Industry Leader Keynote Speakers
ISPE has announced a stellar lineup of keynote speakers, each bringing invaluable experience and insights from various facets of pharmaceutical engineering and bioprocess innovation. The notable speakers include:

• - Chris Grail, Senior VP, Global Pharma Engineering, Bayer AG
• - Jochen Maas, PhD, Former Managing Director, Research and Development, Sanofi
• - Peter Neubauer, PhD, Professor of Bioprocess Engineering, Technische Universität Berlin
• - Kerstin Seemann, Senior VP, Head of Global CMC Development, Merck KGaA
• - Adrian Widmer, Global Head of Digital, AI, and Operational Excellence (Interim), Roche
• - Jan Wokittel, Director and Cluster Lead, Smart Manufacturing, Roche

According to Lineke Pelleboer, Co-Chair of the International Program Committee, this year's roster of keynote speakers uniquely spans diverse disciplines including pharmaceutical engineering, digital manufacturing, and product development. Their insights will undoubtedly help attendees grasp the technologies and strategies that will shape the future of Pharma 4.0™ and biopharma.

Conference Highlights
Attendees are encouraged to explore practical approaches to digital transformation, which are critical to evolving pharmaceutical operations in our digital age. The conference aims to address complex topics such as:

• - Data readiness
• - AI enablement
• - Smart manufacturing integration
• - Compliance processes
• - Scalable operations in the biopharma sector

With real-world examples and lessons from industry leaders, attendees can engage actively in discussions that drive these advancements forward. Markus Zeitz, Co-Chair of the International Program Committee, emphasizes that this conference is an opportunity for participants to learn firsthand about the challenges and opportunities presented by digital transformation in biopharma.

Technical Tracks
The program is designed with three main technical tracks:
1. Pharma 4.0™ Enabling Digital Foundations
2. Pharma 4.0™ Compliant by Design
3. Pharma 4.0™ in Action: Biopharma Manufacturing Transformation

These tracks promote knowledge sharing and collaboration among professionals deeply invested in transforming the pharmaceutical landscape.

Register Now
For those interested in participating in this pivotal conference, registration is now open at ISPE.org/26Pharma.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is a nonprofit organization committed to advancing the pharmaceutical industry through technical education and leadership. With over 25,000 members across more than 120 countries, ISPE plays a crucial role in addressing the industry's complex challenges through innovations and collaborations. Established in 1980, ISPE operates its headquarters in North Bethesda, Maryland, USA.

This conference marks a significant milestone in equipping professionals with the knowledge and networks required to excel in the pharmaceutical and biopharmaceutical sectors. Don’t miss out on the chance to be part of this transformative event!